Epidemiology of liver cancer in South Korea
Open Access
- 1 March 2018
- journal article
- review article
- Published by The Korean Association for the Study of the Liver in Clinical and Molecular Hepatology
- Vol. 24 (1), 1-9
- https://doi.org/10.3350/cmh.2017.0112
Abstract
Liver cancer is the sixth most common cancer 9fourth in men and sixth in women) and the second largest cause of cancer mortality in South Korea. The crude incidence rate of liver cancer was 31.9/100,000 947.5/100,000 in men and 16.2/100,000 in women) and the age- standardized incidence rate was 19.9/100,000 932.4/100,000 in men and 8.8/100,000 in women) in 2014. The crude incidence rate increased from 1999 to 2011 and thereafter showed a subtle decreasing tendency. The crude prevalence rate was 113.6/100,000 9170.2/100,000 in men and 57.1/100,000 in women) and the age- standardized prevalence rate was 72.6/100,000 9115.7/100,000 in men and 33.7/100,000 in women) in 2014, which increased from 2010 to 2014. Survival from liver cancer has improved over the last two decades. The 5-year relative survival rate was markedly increased from 10.7% in those diagnosed with liver cancer between 1993 and 1995 to 32.8% in those diagnosed between 2010 and 2014. The epidemiology of liver cancer is influenced by that of underlying liver diseases such as viral hepatitis. Substantial progress has been made in the prevention and treatment of viral hepatitis; however, uncontrolled alcoholic liver disease, obesity and diabetes appears to have the potential to emerge as major causes for liver cancer. Depending on the success of the control of risk factors, the epidemiology of liver cancer in Korea may change.Funding Information
- National Cancer Center (#1510520)
This publication has 23 references indexed in Scilit:
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?Hepatology, 2014
- Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic areaJournal of Gastroenterology and Hepatology, 2014
- Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinomaBMC Cancer, 2013
- Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti‐HBsJournal of Medical Virology, 2013
- A nationwide seroepidemiology of hepatitis C virus infection in South KoreaLiver International, 2013
- Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long‐term clinical outcomes of 1717 treatment‐naïve patients with hepatocellular carcinomaLiver International, 2012
- Hepatocellular carcinomaThe Lancet, 2012
- Relative Etiological Role of Prior Hepatitis B Virus Infection and Nonalcoholic Fatty Liver Disease in the Development of Non-B Non-C Hepatocellular Carcinoma in a Hepatitis B-Endemic AreaDigestion, 2011
- Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 2008